CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine,Immunology,Immunology and Allergy
Reference50 articles.
1. GLOBOCAN 2008;Ferlay,2012
2. Instituto Nacional de Câncer (INCA), http://www.inca.gov.br/estimativa/2012 (09 February 2012, date last accessed).
3. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation;De Nunzio;Eur Urol,2011
4. The natural history of benign prostatic hyperplasia what have we learned in the last decade;Kirby;Urology,2000
5. Inflammation and chronic prostatic diseases: evidence for a link?;Sciarra;Eur Urol,2007
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of CCR2-V64I on the Susceptibility of Patients to Cancer;European Journal of Cancer Care;2023-06-23
2. Prostate tumor markers: diagnosis, prognosis and management;Genetics and Molecular Biology;2023
3. The role of FASL, BCL-2 and BAX polymorphisms in brazilian patients with prostate cancer and benign prostatic hyperplasia;Molecular Biology Reports;2022-08-21
4. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?;Cancers;2021-12-16
5. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population;Frontiers in Immunology;2021-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3